Libros importados con hasta 50% OFF + Envío Gratis a todo USA  Ver más

menu

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada cardiovascular pharmacogenetics (in English)
Type
Physical Book
Illustrated by
Publisher
Year
2004
Language
Inglés
Pages
407
Format
Hardcover
Dimensions
23.4 x 15.5 x 2.8 cm
Weight
0.73 kg.
ISBN
3540402047
ISBN13
9783540402046

cardiovascular pharmacogenetics (in English)

Martin R. Wilkins (Illustrated by) · Springer · Hardcover

cardiovascular pharmacogenetics (in English) - Wilkins, Martin R.

Physical Book

$ 312.62

$ 329.99

You save: $ 17.37

5% discount
  • Condition: New
It will be shipped from our warehouse between Friday, June 28 and Monday, July 01.
You will receive it anywhere in United States between 1 and 3 business days after shipment.

Synopsis "cardiovascular pharmacogenetics (in English)"

The Human Genome Project was sold to the general public largely on the basis that a complete picture of the structure of human DNA would lead to new and better medicines. These medicines would be better because they would be tailored to individual patients, maximising the chances of a therapeutic response and mi- nimising the risks of an adverse event. Taking the idea further, pundits have pre- dicted that the time will come when we could carry our DNA on a card which could be read rapidly and enable the physician to choose the best drug. This is the future. This is pharmacogenetics. When the draft human DNA sequence was announced and scientists were as- ked how this would help drug development, the example most frequently given was the debrisoquine model - where poor metabolisers of this hypotensive agent are exposed to higher plasma levels from a standard dose and at risk of collapse from excessive hypotension. This observation was made over 20 years ago and predated designs to sequence the human genome. Nonetheless, it raised aware- ness of variation in drug metabolism and was correctly assigned to genetic poly- morphisms affecting CYP2D6. Together with the discovery of pseudocholinestera- se deficiency, it marked the birth of pharmacogenetics. The debrisoquine example is an interesting one and worthy of further analysis.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Hardcover.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews